Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

ASCO calls for increased federal funding in cancer research
January 2016
SHARING OPTIONS:

ALEXANDRIA, Va.—Dr. Julie M. Vose, president of the American Society of Clinical Oncology (ASCO), recently issued a statement regarding Congress’ upcoming allocation of “$25 billion in additional non-defense discretionary spending for fiscal year 2016,” calling on Congress for “a bold reinvestment in cancer research.” Vose noted that by 2030, cancer is expected to be the leading cause of death in the United States.
 
“Research funded by NIH is the basis for the most important cancer breakthroughs of our time, but years of inadequate federal funding threaten this progress. Over the past decade, federal funding for the NCI has decreased by 23 percent,” said Vose. “We are continuing to identify unique molecular and genetic drivers of cancer and develop more effective treatments that target them, but the full promise of personalized medicine will not be achieved if our research infrastructure continues to erode.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.